Assignee profile:

Clexio Biosciences Ltd.

City:

Jerusalem

Country:

Israel

Published Applications:

35

Last publication date:

2024-07-25

Patent Grants:

28

Last grant date:

2025-03-04

Top Inventors for applications by Clexio Biosciences Ltd.

These are the the leading inventors for applications assigned to Clexio Biosciences Ltd.:

Recent patent applications by Clexio Biosciences Ltd.

Clexio Biosciences Ltd. based in Jerusalem, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-07-25
US20240245638A1
Human necessities

Method of Treating Parkinson's Disease

#2 | 2024-02-01 ✅ Patent 12,239,634 granted on 2025-03-04
US20240033252A1
Human necessities

Methods of treating pruritus

#3 | 2023-12-14
US20230398098A1
Human necessities

TOPICAL DETOMIDINE FORMULATIONS

#4 | 2023-09-28 ✅ Patent 11,992,468 granted on 2024-05-28
US20230301941A1
Human necessities

Abuse-deterrent dosage forms containing esketamine

#5 | 2023-07-27 ✅ Patent 11,957,645 granted on 2024-04-16
US20230233487A1
Human necessities

Method of treating major depressive disorder

#6 | 2023-06-08
US20230172909A1
Human necessities

TOPICAL DETOMIDINE FORMULATIONS

#7 | 2023-04-27 ✅ Patent 11,964,120 granted on 2024-04-23
US20230131186A1
Human necessities

Long acting gastric residence system

#8 | 2022-11-24
US20220370347A1
Human necessities

TREATMENT OF NOCTURNAL SYMPTOMS AND MORNING AKINESIA IN SUBJECTS WITH PARKINSON'S DISEASE

#9 | 2022-04-28 ✅ Patent 12,016,832 granted on 2024-06-25
US20220125742A1
Human necessities

Method of treating major depressive disorder

#10 | 2022-04-14 ✅ Patent 11,534,409 granted on 2022-12-27
US20220110879A1
Human necessities

Immediate release abuse-deterrent granulated dosage forms

#11 | 2022-03-10 ✅ Patent 11,844,796 granted on 2023-12-19
US20220071990A1
Human necessities

Immediate release abuse-deterrent granulated dosage forms

#12 | 2022-02-24 ✅ Patent 11,903,928 granted on 2024-02-20
US20220054456A1
Human necessities

Methods of treating pruritus

#13 | 2022-02-10
US20220040090A1
Human necessities

Finished Fibrous Structures and Methods of Their Use and Preparation

#14 | 2022-01-13
US20220008334A1
Human necessities

GASTRIC RETENTIVE DEVICES

#15 | 2021-12-02 ✅ Patent 11,547,839 granted on 2023-01-10
US20210370033A1
Human necessities

Long acting gastric residence system

#16 | 2021-07-29 ✅ Patent 11,253,487 granted on 2022-02-22
US20210228505A1
Human necessities

Method of treating major depressive disorder

#17 | 2021-03-25 ✅ Patent 11,730,702 granted on 2023-08-22
US20210085617A1
Human necessities

Immediate release abuse-deterrent granulated dosage forms

#18 | 2020-12-31 ✅ Patent 11,648,198 granted on 2023-05-16
US20200405635A1
Human necessities

Expandable gastroretentive dosage form

#19 | 2020-12-03 ✅ Patent 11,577,061 granted on 2023-02-14
US20200376242A1
Human necessities

Gastric residence system

#20 | 2020-11-19 ✅ Patent 11,389,398 granted on 2022-07-19
US20200360273A1
Human necessities

Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease

#21 | 2020-11-12 ✅ Patent 11,324,707 granted on 2022-05-10
US20200352881A1
Human necessities

Abuse-deterrent dosage forms containing esketamine

#22 | 2020-11-05 ✅ Patent 11,185,532 granted on 2021-11-30
US20200345698A1
Human necessities

Methods of treating pruritus

#23 | 2020-10-29
US20200338287A1
Human necessities

NASAL DELIVERY DEVICES AND METHODS OF USE THEREOF

#24 | 2020-05-21 ✅ Patent 11,207,318 granted on 2021-12-28
US20200155544A1
Human necessities

Immediate release abuse-deterrent granulated dosage forms

#25 | 2020-05-14 ✅ Patent 11,865,088 granted on 2024-01-09
US20200147005A1
Human necessities

Method of treating major depressive disorder

#26 | 2020-01-30 ✅ Patent 10,737,079 granted on 2020-08-11
US20200030589A1
Human necessities

Gastric residence system

#27 | 2020-01-02 ✅ Patent 12,036,189 granted on 2024-07-16
US20200000748A1
Human necessities

Method of treating major depressive disorder

#28 | 2019-12-05 ✅ Patent 11,285,102 granted on 2022-03-29
US20190365646A1
Human necessities

Expandable gastroretentive dosage form

#29 | 2019-05-09 ✅ Patent 10,888,528 granted on 2021-01-12
US20190133961A1
Human necessities

Immediate release abuse-deterrent granulated dosage forms

#30 | 2019-05-09 ✅ Patent 11,185,495 granted on 2021-11-30
US20190133929A1
Human necessities

Finished fibrous structures and methods of their use and preparation

#31 | 2018-12-27 ✅ Patent 11,147,766 granted on 2021-10-19
US20180369138A1
Human necessities

Gastric retentive devices

#32 | 2018-10-25 ✅ Patent 10,406,154 granted on 2019-09-10
US20180303827A1
Human necessities

Transdermal dosage form

#33 | 2018-07-05 ✅ Patent 10,568,881 granted on 2020-02-25
US20180185354A1
Human necessities

Immediate release abuse-deterrent granulated dosage forms

#34 | 2017-06-08 ✅ Patent 10,195,143 granted on 2019-02-05
US20170157043A1
Human necessities

Devices and methods for preparing gastroretentive dosage forms

#35 | 2015-12-03 ✅ Patent 10,485,758 granted on 2019-11-26
US20150342877A1
Human necessities

Expandable gastroretentive dosage form

Also check out Clexio Biosciences Ltd.'s (Jerusalem, Israel) applicant profile with 34 patent applications submitted.

AssigneeID:

143186 ⎘